Seshadri Neervannan

Chief Operating Officer, Tarsus Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.0M

Companies

Latest trade

Sep 4, 2026

Companies

Tarsus Pharmaceuticals, Inc.Chief Operating Officer −$2.0M

Trades

TARS Sold 4,564 shares at $85.00 · planned $0.4M Sep 4

TARS Sold 2,989 shares at $66.75 · planned $0.2M Mar 20

TARS Sold 4,589 shares at $67.00 $0.3M Mar 19

TARS Sold 3,610 shares at $68.71 $0.2M Mar 18

TARS Sold 3,125 shares at $69.42 $0.2M Mar 17

TARS Sold 8,366 shares at $76.67 · planned $0.6M Mar 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.